Wave Life Sciences Ltd.
(WVE)
undefined
undefined%
At close: undefined
13.44
0.07%
After-hours Dec 13, 2024, 05:19 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -57.51M | -161.82M | -122.25M | -149.91M | -193.64M | -146.65M | -102.03M | -55.40M | -19.20M | -5.23M | -3.32M |
| Depreciation & Amortization | 9.21M | 10.11M | 9.84M | 9.98M | 9.20M | 5.58M | 2.15M | 784.00K | 594.00K | 281.00K | 276.00K |
| Stock-Based Compensation | 9.79M | 17.19M | 16.41M | 14.30M | 19.51M | 15.60M | 12.14M | 6.85M | 4.02M | - | - |
| Other Working Capital | 43.93M | -2.63M | -18.46M | -20.08M | -24.35M | 160.53M | -4.19M | 12.84M | -152.00K | 152.00K | 81.00K |
| Other Non-Cash Items | - | 12.00K | 12.64M | 9.14M | 31.41M | 183.00K | 3.59M | 565.00K | 88.00K | -6.00K | -6.00K |
| Deferred Income Tax | - | - | -12.64M | -9.14M | -31.41M | 44.00K | 774.00K | -874.00K | 36.00K | 84.00K | -330.00K |
| Change in Working Capital | 19.08M | 6.72M | 7.01M | 9.65M | -23.30M | 102.39M | -299.00K | 16.21M | 1.93M | 430.00K | -173.00K |
| Operating Cash Flow | -19.43M | -127.78M | -88.99M | -115.98M | -188.23M | -22.86M | -83.67M | -31.87M | -12.53M | -4.43M | -3.55M |
| Capital Expenditures | -1.11M | -1.36M | -560.00K | -1.34M | -3.92M | -9.94M | -18.89M | -5.57M | -1.86M | -590.00K | -47.00K |
| Acquisitions | - | 106.00K | - | - | - | - | - | 4.00K | 3.00K | - | - |
| Purchase of Investments | - | -75.04M | - | - | - | - | - | -2.60M | -1.05M | - | - |
| Sales Maturities Of Investments | - | 75.04M | - | - | - | - | - | - | - | - | - |
| Other Investing Acitivies | - | 106.00K | - | - | -3.92M | -9.94M | -9.00K | -2.60M | -1.05M | 333.00K | - |
| Investing Cash Flow | -1.11M | -1.25M | -560.00K | -1.34M | -3.92M | -9.94M | -18.90M | -8.16M | -2.91M | -257.00K | -47.00K |
| Debt Repayment | - | - | - | - | - | -16.00K | -62.00K | -62.00K | -126.00K | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 1.26M | 14.86M | 858.00K | 912.00K | 2.61M | 5.11M | 927.00K | -817.00K | 62.64M | 34.00K | 3.67M |
| Financial Cash Flow | 132.53M | 67.19M | 55.83M | 154.54M | 164.40M | 65.09M | 94.37M | 29.12M | 175.59M | 5.62M | 3.67M |
| Net Cash Flow | 111.89M | -62.06M | -33.93M | 37.34M | -27.64M | 32.33M | -7.79M | -10.93M | 160.17M | 609.00K | 60.00K |
| Free Cash Flow | -20.55M | -129.14M | -89.55M | -117.32M | -192.15M | -32.80M | -102.56M | -37.44M | -14.38M | -5.02M | -3.60M |